TCL Archive Faulty Estimates Led NCI To Overstate Black-White Cancer Disparity In Atlanta September 20, 2002
TCL Archive Commerce Dept. Socks NCI For Cancergram Paid Subscriptions; NCAB Committee Oks OD Requests October 22, 1982
TCL Archive Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation April 17, 2009
TCL Archive FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer. July 27, 2007